Blue Chip Stocks Growth Stocks Undervalued Stocks

The Next Wave of ASX Breakouts: Here are 7 Stocks Best Positioned to Follow the Leaders

Everyone is looking for the next wave of ASX breakouts because they happen in every market cycle. Investors still look back at those stories as proof that the ASX can…

ByNick Sundich

26

May 2026

Biotech Stocks Healthcare Stocks Small Caps Stocks

Aroa Biosurgery (ASX:ARX) prints NZ$12.6m EBITDA then guides it lower for FY27

Aroa Biosurgery (ASX:ARX) printed NZ$12.6m EBITDA in FY26 then guided FY27 lower as it reinvests NZ$9m into Myriad and Symphony.

ByCharlie Youlden

24

Jan 2026

Healthcare Stocks

Aroa Biosurgery (ASX: ARX): Why This Newly Profitable Medtech Looks Like a Buy at Current Levels

Aroa Biosurgery adds new trauma study as profits turn positive Aroa Biosurgery (ASX: ARX) shares have seen increased activity this week, hovering around the A$0.70 level following news that…

ByUjjwal Maheshwari

The Next Wave of ASX Breakouts: Here are 7 Stocks Best Positioned to Follow the Leaders

Aroa Biosurgery (ASX:ARX) prints NZ$12.6m EBITDA then guides it lower for FY27

Aroa Biosurgery (ASX: ARX): Why This Newly Profitable Medtech Looks Like a Buy at Current Levels

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

The Next Wave of ASX Breakouts: Here are 7 Stocks Best Positioned to Follow the Leaders

Aroa Biosurgery (ASX:ARX) prints NZ$12.6m EBITDA then guides it lower for FY27

Aroa Biosurgery (ASX: ARX): Why This Newly Profitable Medtech Looks Like a Buy at Current Levels

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here